baber/WOPTO huggingface dataset:
Patent JP-3095157-B2 (JP)
IPC: H04N9/79
Filed: 1991-12-20
Granted: 2000-10-03
Abstract: A color corrector for correcting chromaticity of a color image to be reproduced is provided in a color printer or a CRT display device for reproducing a color image from respective signals corresponding to predetermined primary colors of a plurality of primary colors constituting the color image. This color corrector comprises: a corrective operation circuit for executing an operation between a color correction coefficient matrix and signals corresponding to the primary colors to correct relative levels of the signals corresponding to the primary colors; a gray component extraction circuit for making level comparison between the signals corresponding to the primary colors to thereby extract a gray component; a correction signal output circuit for executing an operation between the extracted gray component and correction coefficients determined by the matrix to output gray balance correction signals every primary colors; and an adding circuit for adding signals of which levels are corrected in correspondence with respective primary colors outputted from the corrective operation circuit to outputs from the correction signal output circuit. <IMAGE>
Patent JP-3195452-B2 (JP)
IPC: C07C401/00
Filed: 1992-12-28
Granted: 2001-08-06
Abstract: Vitamin D2 analogs in which a cyclopentane ring is introduced onto the 25-carbon of the side chain of 1 alpha ,25-dihydroxyvitamin D2 and its 24-epimer are described. The compounds are characterized by a marked intestinal calcium transport activity while exhibiting much lower activity than 1 alpha ,25-dihydroxyvitamin D3 in their ability to mobilize calcium from bone. Because of their preferential calcemic activity, these compounds find utility in the treatment of diseases where bone formation is desired, such as osteoporosis.
Patent JP-2501661-B2 (JP)
IPC: C03B18/16
Filed: 1990-12-20
Granted: 1996-05-29
Abstract: In a float glass chamber, particularly in a region operating at higher than usual temperatures, integrity of the bottom structure is sustained by employing wedge shaped bottom blocks that are maintained in compression by externally applied mechanical forces. The arrangement permits the use of a bi-layer bottom construction with a high alumina upper course and a clay bottom course.
Patent JP-3883137-B2 (JP)
IPC: A61K31/66
Filed: 1995-06-02
Granted: 2007-02-21
Abstract: The present invention relates to certain optionally ring substituted pyridinylaminomethylidene bisophosphonic acid tetralkyl esters (I) and their use for the treatment of bone diseases, such as osteolytic bone diseases due to malignancy, Paget's disease and primary and secondary osteoporosis.
Patent JP-S6021994-B2 (JP)
IPC: C07D495/04
Filed: 1981-05-06
Abstract: The new compounds, defined as thieno-benzodiazepinones, are represented by the general formula I,  (FORMULA)  wherein R<s1>s represents a hydrogen atom or an alkyl residue from C<u1>u to C<u4>u, R<s2>s represents a halogen atom or has the same representation as R<s1>s, and R<s3>s represents a halogen atom or a group-N (R<s4>s)R<s5>s, wherein R<s4>s represents an alkyl residue from C<u1>u to C<u4>u or an alkenyl residue from C<u3>u to C<u5>u and wherein R<s5>s has one of the representations of R<s4>s or represents a group having the partial formula -(CH<u2>u)<um>u-N (R<s6>s)R<s7>s, or wherein R<s4>s and R<s5>s in common, including the nitrogen atom to which they are bound, represent a morpholino, pyrrolidino, piperidino group, a hexa-hydro-azepin-1-yl group, a piperazine-1-yl group optionally substituted in position 4 by methyl or ethyl or benzyl, a 2, 4-dimethyl-piperazine-1-yl group or an hexa-hydro-1H-1, 4-diazepin-1-yl group substituted in position 4 by methyl or ethyl, the symbol R<s6>s representing an alkyl group in C<u1>u to C<u4>u and R<s7>s representing an alkyl group in C<u1>u to C<u4>u, the symbol A of the formula I represents an alkylen group with a straight or branched chain C<u1>u to C<u5>u and the symbol m hereabove is 2 or 3; their addition salts may also be formed. All these compounds exhibit a pharmacologic activity for the protection of the stomach and intestine organs and are therefore appropriate for the treatment of diseases affecting the stomach or intestine organs; these compounds may also be used as intermediary products. There are also disclosed methods for the preparation of said new compounds which exhibit an interesting pharmacological activity and also form intermediary products.
Patent JP-H0798973-B2 (JP)
IPC: C23C8/22
Filed: 1988-03-01
Abstract: A continuous carburizing furnace system is disclosed having at least two series-connected rotary furnaces. The rotary carburizing furnace, a rotary equalizing furnace, and a rotary diffusion furnace which may be included between the carburizing and equalizing furnaces, allow trays of parts to be discharged from any position at any time by suitable rotation of their hearths, thus allowing parts with different cycle times to be run simultaneously in each rotary furnace. Each donut-shaped rotary furnace includes one or more captive chain type pusher mechanisms mounted in vertical fashion within a central area or hole, and the rotary carburizing furnace is multi-zoned and includes wall-mounted fans for uniform circumferential control of the gaseous atmosphere within its annular chambers. Two different quenching apparatuses and a slow cool assembly adjacent multiple outlets of the equalizing furnace permit the use of different cooling/quenching processes on selected parts, and parts may also be returned from the slow cool assembly to the equalizing furnace for reheating.
Patent JP-4160640-B2 (JP)
IPC: A61P11/00
Filed: 1998-06-19
Granted: 2008-10-01
Abstract: The invention relates to the identification of members of a gene family from the human respiratory pathogen Chlamydia pneumoniae, encoding surface exposed membrane proteins of a size of approximately 89-101 kDa, preferably about 89.6-100.3 kDa and about 56.1 kDa. The invention relates to the novel DNA sequences, the deduced amino acid sequences of the corresponding proteins and the use of the DNA sequences and the proteins in diagnosis of infections caused by C. pneumoniae, in pathology, in epidemiology, and as vaccine components.
Patent JP-3488469-B2 (JP)
IPC: A23L35/00
Filed: 1996-06-14
Granted: 2004-01-19
Abstract: The present invention relates to stable beverage products. The beverage products of the present invention comprise of an oil-in-water beverage emulsion which comprises an unweighted oil, water and a food grade stabilizer. The ratio of the stabilizer to the unweighted oil within the beverage emulsion is at least about 0.5:1. The mean particle size of the oil droplets present in the emulsion ranges from about 0.10 to about 0.30 microns. The particle size distribution of the oil droplets in the emulsion is such that less than about 3% (volume percent basis) of the particles have a particle size greater than about 0.39 microns and less than about 9% (volume percent basis) of the particles have a particle size of greater than about 0.34 microns The beverage products of the present invention further comprise a fruit juice and/or fruit or other flavor.
Patent JP-2706571-B2 (JP)
IPC: E05D11/10
Filed: 1992-10-21
Granted: 1998-01-28
Abstract: The invention relates to a method for storing and mounting the body for a cabinet, furniture or the like, consisting of two sides (2, 3), top (1) and base (4), where adjacent end sections of said sides, top and base are provided with articulation devices (6, 7, 8, 11) to join the parts together. Said sides, top and base are arranged in transport or storage state such that said top and one of the sides (1, 2) lie parallel with said base and the other side (3, 4). The body is mounted by moving said two sides (2, 3), together with the top (1) and base (4), in mutually parallel relationship like a parallellogram until said two sides (2, 3) are vertical, whereafter at least one of the two sets of articulation devices (6, 8) situated diagonally in the body is releasably locked into position. The means for forming an articulated joint between adjacent end sections of the structural parts, e.g., sides, top and base of a body for a cabinet or the like, comprises a cup-shaped body (6, 7, 8) which is hinge-connected to an approximately L-shaped (8'), U-shaped (6') or stepped straight arm. The arm may be equipped with a rotatable tension pin adapted for engagement with a recess in the member.
Patent JP-2902481-B2 (JP)
IPC: C10L1/22
Filed: 1991-04-19
Granted: 1999-06-07
Abstract: PCT No. PCT/GB91/00622 Sec. 371 Date Oct. 13, 1992 Sec. 102(e) Date Oct. 13, 1992 PCT Filed Apr. 19, 1991 PCT Pub. No. WO91/16407 PCT Pub. Date Oct. 31, 1991.Polymer of number average molecular weight 1,000 to 20,000 containing the repeating units (I) (II) or (III) (II) have been found useful as low temperature flow improvers for distillate fuels particularly in combination with other additives.
Patent JP-2818486-B2 (JP)
IPC: C12Q1/68
Filed: 1991-02-12
Granted: 1998-10-30
Abstract: A process is provided for detecting polymorphisms on the basis of nucleotide differences in random segments of the nucleic acid by performing a primer extension reaction on the nucleic acids and comparing the extension reaction products. The random nucleic acid segment can be amplified by first dissociating the extension product from the template and contacting the dissociated extension product with a primer under conditions such that an amplification extension product is synthesized using the dissociated extension product as a template. Differences in the extension product are useful as markers in constructing genetic maps and as markers to distinguish or identify individuals.
Patent JP-2763963-B2 (JP)
IPC: A61F2/00
Filed: 1994-09-01
Granted: 1998-06-11
Abstract: An apparatus for electrosurgical incision of a stricture within or adjacent to a body lumen, which comprises an electrically conducting, deflectable wire associated with an introducer for introducing the apparatus into the body lumen, wherein a proximal portion of the wire is deflectable outwardly relative to the introducer, and a source of RF electric current connected to the wire whereby RF electric current may be transmitted through the wire when it is in the deflected position.
Patent JP-3357375-B2 (JP)
IPC: A61G7/012
Filed: 1996-09-24
Granted: 2002-12-16
Abstract: The support and control appts. includes a frame (16), and an upwardly facing patient support surface (40) with a perimeter carried by the frame. An air generator is mounted on the frame and provides two curtains of air. Each air curtain originates adjacent to the perimeter and converges at a point above the patient support surface. The curtains combine with the support surface to define a patient space. A third curtain of air is provided originating adjacent to the perimeter of the support surface and directed into the patient space. A fourth air curtain opposes the third and is directed into the patient's space.
Patent JP-3463065-B2 (JP)
IPC: G09B9/06
Filed: 1991-08-01
Granted: 2003-11-05
Abstract: A driver training system (100) for a user (102) of a simulated vehicle. The system includes input devices (104, 106, 108, 110, 112) for controlling the simulated vehicle, a video display (122) having three-dimensional graphics, modeling software (116) for determining position information based on the input devices, and recursive training software (120) to display a previous route through an environment simultaneously with a present route (134) through the environment. The user then incrementally and recursively maximizes parameters associated with vehicle operation skill. The driver training system (100) may be embodied as an arcade game.
Patent JP-3902223-B2 (JP)
IPC: C21C7/064
Filed: 1993-02-25
Granted: 2007-04-04
Abstract: PCT No. PCT/DE93/00165 Sec. 371 Date Aug. 29, 1994 Sec. 102(e) Date Aug. 29, 1994 PCT Filed Feb. 25, 1993 PCT Pub. No. WO93/17131 PCT Pub. Date Sep. 2, 1993.The invention relates to a method and apparatus for desulphurizing iron with minimal slag formation, comprising the steps of melting and heating, to a temperature of about 1400 DEG  to 1800 DEG  C., a slag having the following chemical composition: 20% max SIO2; 30% max/Al2O3; about 5-40% SiO2+Al2O3+TiO2 combined; 2% max FeO; 1.5% max MnO; about 25-65% CaO+MgO+BaO+Na2O+K2O; 20% max MgO; 10% max Na2O+K2O; 60% max CaF2; about 50-85% CaO+MgO+BaO+Na2O+K2O+CaF2; percentages by weight; where the ratio of the percentage by weight of CaO plus MgO divided by the percentage by weight of SiO2 plus one-half Al2O3 is at least two and where the ratio of the percentage by weight of Na2O plus K2O to SiO2 is no more than one; then mixing the sulphur-containing hot metal with this bath of molten slag so as not to exceed 10 parts molten iron per part slag by weight. The desulphurized molten iron is then drawn from beneath the slag bath. The process may be accomplished using a low shaft furnace according to the present invention comprising a furnace body lined with carbon bricks or carbonaceous, basic or high-alumina refractory bricks and having a discharge pipe extending down to the bottom of the furnace chamber for discharging the desulphurized molten iron from beneath the slag bath.
Patent JP-3896158-B2 (JP)
IPC: H01L29/82
Filed: 1993-12-03
Granted: 2007-03-22
Abstract: A single mask, low temperature reactive ion etching process for fabricating high aspect ratio, released single crystal microelectromechanical structures independently of crystal orientation.
Patent JP-3492369-B2 (JP)
IPC: G02B27/00
Filed: 1994-02-02
Granted: 2004-02-03
Abstract: An optical instrument is described in which a diffractive element (25) is located at a focal or image plane (3) of the instrument and the diffractive element (25) is effective to produce an array (6) of a plurality of exit pupils at a viewing position for the instrument and thereby to form an enlarged exit pupil for the instrument.
Patent JP-4150425-B2 (JP)
IPC: G06Q30/00
Filed: 1997-05-23
Granted: 2008-09-17
Abstract: A global standard messaging system and process for allowing customers to access a full range of global financial services using a variety of access points. The system includes a global communications network that integrates customer information and makes the information accessible from remote locations. The system includes a comprehensive database assembled from diverse sources and systems and processes for retrieving the information from the central database in a meaningful and practical way. The system includes several levels of access communications as well as built-in flexibility so that it can be accessed by a variety of remote systems of varying degrees of complexity and language. System and process permit rapid communication among worldwide users of the service as may be desired by industries relating to the transfer of finances.
Patent JP-4562814-B2 (JP)
IPC: C07K16/18
Filed: 1998-03-31
Granted: 2010-10-13
Abstract: The present invention relates to the use of insulin-like growth factor agonist molecules for the preparation of a pharmaceutical composition for the stimulation of cartilage growth. These compositions inhibit the interaction of an IGF with any (one) of its binding proteins but do not bind to a human IGF receptor.
Patent JP-4162155-B2 (JP)
IPC: A61K48/00
Filed: 1998-05-20
Granted: 2008-10-08
Abstract: New polypeptide comprises an immunogenic portion of a Mycobacterium tuberculosis antigen (or a variant of the antigen differing only by conservative substitutions and/or modifications), in which the antigen comprises one of the 23 amino acid sequences (given in the specification) or the antigen is encoded by: (i) one of the 23 DNA sequences (given in the specification) encoding the 23 amino acid sequences; (ii) sequences hybridising to (i) under moderately stringent conditions, or (iii) sequences complementary to (i) or (ii). Also claimed are: (1) DNA molecules encoding the polypeptide; (2) expression vectors comprising (1); (3) host cells (optionally E. coli, yeast or mammalian) comprising vector; (4) compositions comprising DNA molecule with one of the 11 nucleotide sequences (given in the specification) and a carrier; (5) fusion proteins comprising polypeptide and known M. tuberculosis antigen or comprising at least two of polypeptides, and (6) vaccines comprising non-specific immune response enhancer (optionally an adjuvant) and polypeptide/DNA/fusion protein/DNA sequence of (C)/polypeptide encoded by sequences of (4) or complementary or hybridising sequences.
Patent ES-2472341-B2 (ES)
Title: Cápsula para elaboración de bebida
Inventor: FLORES ARNAIZ JESUS GUILLERMO
IPC: B65D85/804
Filed: 2012-12-31
Granted: 2015-11-03
Abstract: Cápsula para elaboración de bebida que comprende un contenedor con una tapa a través de la que se realiza una inyección de un fluido a presión en una cámara superior de contención de un producto alimenticio, en cuyo fondo, anular, asienta una placa de filtro que cierra inferiormente dicha cámara superior, comprendiendo la placa de filtro unos orificios de paso del fluido mezclado con el producto alimenticio, que comprende: una cámara intermedia de contención de aromas y gas inerte a continuación de la cámara superior y bajo la placa de filtro, en cuyo fondo, anular, asienta: una micro-membrana de cierre estanco de la cámara intermedia, que cierra inferiormente dicha cámara intermedia sellando su fondo, el cual, al romperse únicamente por aumento de la presión en dicha cámara intermedia abre paso a: una cámara de descarga, situada a continuación de la cámara intermedia y bajo la micro-membrana, de amortiguamiento de la caída del producto alimenticio hacia el exterior, que deja paso del fluido mezclado con el producto alimenticio, favoreciendo así el arrastre de los aromas hacia el exterior de la cápsula.
Patent ES-2589165-B2 (ES)
Title: COMBINACIÓN QUE COMPRENDE GALANINA Y (Leu31,Pro34) NPY; USOS Y MÉTODOS
Inventor: NARVAEZ PELAEZ MANUEL
IPC: A61P25/24
Filed: 2015-11-20
Granted: 2018-11-15
Abstract: Combinación que comprende galanina y [Leu31,Pro34]NPY; usos y métodos. La invención se refiere a una combinación que comprende galanina y [Leu31,Pro34]NPY. Adicionalmente, la invención refiere usos de dicha combinación y medicamentos que la comprenden, dirigidos a uso terapéutico frente a una enfermedad del sistema nervioso, particularmente depresión.
Patent AU-2001274195-B2 (AU)
Title: Use of riluzole or its salts for preventing and treating adrenoleukodystrophy
Inventor: DIB MICHEL
IPC: C07D277/82
Filed: 2001-06-05
Granted: 2005-12-01
Abstract: The invention concerns the use or riluzole of one of is pharmaceutically acceptable salts for preventing and treating adrenoleukodystrophy.
Patent AU-2001282341-B2 (AU)
Title: Water-soluble packages containing liquid compositions
Inventor: KAISER ROGER
IPC: C11D17/04
Filed: 2001-08-23
Granted: 2006-10-12
Abstract: Abstract of the Disclosure An aqueous liquid composition having a water content of between 20 and 50 wt.%, comprising at least one polyphosphate builder material, potassium ions and sodium ions, wherein the molar ratio of potassium to sodium is between 0.55:1 and 20:1.
Patent AU-2001294196-B2 (AU)
Title: Nitrogenous five-membered ring compounds
Inventor: YASUDA KOSUKE
IPC: C07D405/12
Filed: 2001-10-05
Granted: 2005-11-17
Abstract: The present invention is to provide an aliphatic nitrogen-containing 5-membered ring compound represented by the formula ÄIÜ : <CHEM>  wherein symbols in the formula have the following meanings;     A: -CH2- or -S-,   B: CH or N,   R<1>: H, a lower alkyl group, etc.,   X: a single bonding arm, -CO-, -Alk-CO-, -COCH2-, -Alk-O-, -O-CH2-, -SO2-, -S-, -COO-, -CON(R<3>)-, -Alk-CON(R<3>)-, -CON(R<3>)CH2-, -NHCH2-, etc.,   R<3>: hydrogen atom or a lower alkyl group,   Alk: a lower alkylene group, and   R<2>: (1) a cyclic group which may be substituted, (2) a substituted amino group, etc., provided that when X is -CO-, then B is N, or a pharmaceutically acceptable salt thereof.
Patent AU-2002220093-B2 (AU)
Title: Method and apparatus for treatment of water and wastewater
Inventor: BANERJEE KASHI
IPC: C02F1/38
Filed: 2001-11-02
Granted: 2006-09-14
Abstract: The present invention is directed to a method and apparatus for the treatment of water and wastewater. In one embodiment, a method of treating water according to the present invention includes mixing sludge and precipitant with the water to be treated, mixing ballast with the water, and separating the water into treated water and sludge. Some or all of the separated sludge may be recycled for mixing with the precipitant and water to be treated.
Patent AU-2002236498-B2 (AU)
Title: DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence programmed and cell death in plants
Inventor: THOMPSON JOHN E
IPC: C12N9/02
Filed: 2001-11-29
Granted: 2007-10-11
Abstract: Regulation of expression of programmed cell death, including senescence, in plants is achieved by integration of a gene or gene fragment encoding senescence-induced eIF-5A or both into the plant genome in antisense orientation. Plant genes encoding senescence-induced deoxyhpusine synthase and senescence-induced elF-5A are identified and the nucleotide sequences of each, aon and in combination are used to modify senescence in transgenic plants
Patent AU-2002248340-B2 (AU)
Title: Substituted alkylamine derivatives and methods of use
Inventor: DOMINGUEZ CELIA
IPC: A61P27/02
Filed: 2002-01-11
Granted: 2005-11-03
Abstract: Selected heterocyclic compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Patent AU-2002254955-B2 (AU)
Title: System For Joining Modules With Magnetic Anchorage For The Construction of Stable Grid Structures
Inventor: VICENTELLI CLAUDIO
IPC: G09B1/38
Filed: 2002-03-18
Granted: 2006-07-27
Abstract: In an assembly of modules with magnetic anchorage for the construction of a grid structure, a joining element for connecting rigidly at least a first and a second elongated modules of the grid structure, characterised in that it comprises: a body of the joining element; at least a first and a second tubular projections of the body for axial attachment of the first and respectively second elongated modules; and a housing of the body for securing the body to a further module of the grid structure; the at least first and second tubular projections being in direct communication with the housing for contact of the further module to the at least first and second elongated modules.
Patent AU-2002318846-B2 (AU)
Title: Method of crystallizing reduced coenzyme Q10 from aqueous solution
Inventor: UEDA YASUYOSHI
IPC: C07C43/23
Filed: 2002-07-15
Granted: 2008-06-12
Abstract: Preparation of crystalline reduced coenzyme Q 10comprises crystallizing reduced coenzyme Q 10from aqueous solution.
Patent AU-2002338716-B2 (AU)
Title: Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease
Inventor: HEINZEL THORSTEN
IPC: G01N33/50
Filed: 2002-09-17
Granted: 2007-08-16
Abstract: The present invention relates to the use of the drug valporic acid and derivatives thereof as inhibitors of enzymes having histone deacetylase activity for the manufacture of a medicament to sensitize human cancer cells for treatment efficacy in combination with clinically established anti-cancer therapeutic drugs. The invention also relates to the treatment of tumor metastasis and minimal residual disease.